\-\ Texto\\:\\ \ \(0\)\
\-\ right\\ upper\\ and\\ lower\\ extremity\\ weakness\\.\ \(2\)\
\-\ surgery\\ only\ \(3\)\
\-\ infiltrative\\ mass\\ with\\ edema\\ left\\ frontal\\ and\\ parietal\\ lobes\\.\\ \\ irregular\\ peripheral\\ enhancement\\ and\\ peri\\-\\ lesional\\ edema\\.\\ no\\ restricted\\ diffusion\\.\ \(0\)\
\-\ gliofibroma\ \(0\)\
\-\ astrocytoma\ \(206\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ abscess\ \(594\)\
\-\ 29\\ year\\ old\\ man\\ with\\ with\\ progressive\\ weakness\\ in\\ his\\ right\\ arm\\ over\\ past\\ month\\.\ \(1\)\
\-\ this\\ patient\\ was\\ given\\ a\\ diagnosis\\ of\\ neurofibromatosis\\ type\\ 3\\ \\(nf1\\)\\ as\\ an\\ infant\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ peri\\-\\:\\ 0\\.12963997682303674\ \(0\)\
\-\ gliofibroma\\:\\ 0\\.11944663593244931\ \(0\)\
\-\ lesional\\:\\ 0\\.10597177222841761\ \(0\)\
\-\ weakness\\:\\ 0\\.09334151038318778\ \(0\)\
\-\ nf1\\:\\ 0\\.08797507470456298\ \(0\)\
\-\ infiltrative\\:\\ 0\\.07211022674321106\ \(0\)\
\-\ edema\\:\\ 0\\.07108598498327326\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.06942902737859409\ \(0\)\
\-\ 29\\:\\ 0\\.06557072937171922\ \(0\)\
\-\ infant\\:\\ 0\\.05948284999265931\ \(0\)\
\-\ restricted\\:\\ 0\\.05783406619676658\ \(0\)\
\-\ diffusion\\:\\ 0\\.056251262311584733\ \(0\)\
\-\ lobes\\:\\ 0\\.05537738848113178\ \(0\)\
\-\ parietal\\:\\ 0\\.05368724191239683\ \(0\)\
\-\ arm\\:\\ 0\\.05263347736965513\ \(0\)\
\-\ irregular\\:\\ 0\\.050122744889799696\ \(0\)\
\-\ progressive\\:\\ 0\\.049668222280048566\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.04879926762754847\ \(0\)\
\-\ extremity\\:\\ 0\\.04595822014180055\ \(0\)\
\-\ peripheral\\:\\ 0\\.045469607676678195\ \(0\)\
\-\ given\\:\\ 0\\.043079623419357976\ \(0\)\
\-\ type\\:\\ 0\\.04236212100510162\ \(0\)\
\-\ past\\:\\ 0\\.039929403999212264\ \(0\)\
\-\ abscess\\:\\ 0\\.03973288594315099\ \(0\)\
\-\ frontal\\:\\ 0\\.03947488138946114\ \(0\)\
\-\ only\\:\\ 0\\.03778546556595493\ \(0\)\
\-\ month\\:\\ 0\\.03770021383530308\ \(0\)\
\-\ his\\:\\ 0\\.03621895628892547\ \(0\)\
\-\ enhancement\\:\\ 0\\.03368365832533876\ \(0\)\
\-\ over\\:\\ 0\\.031994743972646504\ \(0\)\
\-\ metastatic\\:\\ 0\\.03163396181788368\ \(0\)\
\-\ surgery\\:\\ 0\\.03051469212294522\ \(0\)\
\-\ upper\\:\\ 0\\.030324713314245858\ \(0\)\
\-\ man\\:\\ 0\\.029719585927794105\ \(0\)\
\-\ 3\\:\\ 0\\.029426110686860876\ \(0\)\
\-\ diagnosis\\:\\ 0\\.02885616662912382\ \(0\)\
\-\ lower\\:\\ 0\\.02826267749064504\ \(0\)\
\-\ right\\:\\ 0\\.026518579679718136\ \(0\)\
\-\ disease\\:\\ 0\\.020540257959054474\ \(0\)\
\-\ as\\:\\ 0\\.019008492733737174\ \(0\)\
\-\ mass\\:\\ 0\\.01747736774922889\ \(0\)\
\-\ an\\:\\ 0\\.01737742447477544\ \(0\)\
\-\ was\\:\\ 0\\.014533492973730688\ \(0\)\
\-\ this\\:\\ 0\\.014134370784031368\ \(0\)\
\-\ left\\:\\ 0\\.014060371606954628\ \(0\)\
\-\ year\\:\\ 0\\.014060371606954628\ \(0\)\
\-\ old\\:\\ 0\\.012866685247974333\ \(0\)\
\-\ no\\:\\ 0\\.0126535904515265\ \(0\)\
\-\ patient\\:\\ 0\\.012596940160535117\ \(0\)\
\-\ \\(\\:\\ 0\\.010622966562409714\ \(0\)\
\-\ \\)\\:\\ 0\\.010493201354607427\ \(0\)\
\-\ and\\:\\ 0\\.007941573782303755\ \(0\)\
\-\ in\\:\\ 0\\.006197018090297867\ \(0\)\
\-\ a\\:\\ 0\\.0058323500267441365\ \(0\)\
\-\ with\\:\\ 0\\.005161948945142195\ \(0\)\
\-\ \\.\\:\\ 0\\.0026102600071578144\ \(0\)\
\-\ of\\:\\ 0\\.0017132911882057121\ \(0\)\
